mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread.

This news item is fetched from a public RSS feed. Title, summary, and image are © their respective publisher; follow the link above to read the full article on the original site.